Informação da revista
Vol. 35. Núm. 9.
Páginas 505-506 (Setembro 2016)
Partilhar
Partilhar
Baixar PDF
Mais opções do artigo
Vol. 35. Núm. 9.
Páginas 505-506 (Setembro 2016)
Image in Cardiology
Open Access
Active fixation coronary sinus lead extraction – A safe procedure
Extração de eletrocateter com sistema de fixação ativa do seio coronário – um procedimento seguro
Visitas
4573
Tatiana Guimarães
Autor para correspondência
, Gustavo Lima da Silva, Ana Bernardes, João de Sousa, Pedro Marques
Serviço de Cardiologia, Hospital de Santa Maria, Centro Académico Médico de Lisboa, CCUL, Lisboa, Portugal
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Baixar PDF
Estatísticas
Figuras (4)
Mostrar maisMostrar menos
Texto Completo

The first active fixation coronary sinus lead was introduced in 2008 (Medtronic Inc., Attain StarFix 4195). Initial enthusiasm for this method of avoiding lead dislodgement was soon replaced by concerns about safety in the event of need for extraction.

The StarFix is a 5F unipolar lead, with a distal active fixation mechanism consisting of deployable lobes that expand to 24F. Deployment is achieved by advancing the outer tubing of the lead. Pulling the lead and advancing the tubing achieves acute repositioning. This mechanism for retraction of the lobes cannot be used in chronically implanted leads due not only to fibrosis involving the lobes but also to the low tension applied on them by the lead being completely inserted in the outer tubing. In our experience we have successfully extracted two of these leads (due to system infection), both implanted for more than 24 months. Extraction was performed in both cases by retracting the fixation lobes. This was achieved by progressively cutting the outer tubing and pressuring the lead with a stylet. After complete retraction of the lobes the lead was pulled out by smooth traction using a lead locking device (LLD®, Spectranetics) (Figures 1–4).

Figure 1.

(A-C) Cutting the outer tubing and pressuring the lead with a stylet.

(0,12MB).
Figure 2.

Fluoroscopic imaging: (A) complete triple-site cardiac resynchronization therapy defibrillator system; (B) active fixation coronary sinus lead, after extraction of both right ventricular leads; (C) initial retraction of the active fixation lead lobes.

(0,07MB).
Figure 3.

Fluoroscopic imaging: (A and B) sequential retraction of the active fixation lead lobes; (C) complete retraction of the lobes and pulling of the lead into the right atrium.

(0,07MB).
Figure 4.

Active fixation coronary sinus lead after extraction.

(0,07MB).
Ethical disclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that no patient data appear in this article.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.

Conflicts of interest

The authors have no conflicts of interest to declare.

Copyright © 2016. Sociedade Portuguesa de Cardiologia
Idiomas
Revista Portuguesa de Cardiologia
Opções de artigo
Ferramentas
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Ao assinalar que é «Profissional de Saúde», declara conhecer e aceitar que a responsável pelo tratamento dos dados pessoais dos utilizadores da página de internet da Revista Portuguesa de Cardiologia (RPC), é esta entidade, com sede no Campo Grande, n.º 28, 13.º, 1700-093 Lisboa, com os telefones 217 970 685 e 217 817 630, fax 217 931 095 e com o endereço de correio eletrónico revista@spc.pt. Declaro para todos os fins, que assumo inteira responsabilidade pela veracidade e exatidão da afirmação aqui fornecida.